EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FDPS links tumor progression, phosphoproteomic reprogramming, and therapeutic vulnerability in hepatocellular carcinoma

Hanxun Yue, Guozhi Wu, Na Jiang, Renpeng Li, Ya Zheng, Yuping Wang, Zenan Hu, Yongning Zhou

Biomolecules and Biomedicine · 2026

DOI: 10.17305/bb.2026.13996 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules and Biomedicine, 2026. Verfasst von Hanxun Yue und 7 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Lanzhou University, Lanzhou, China; Department of Gastroenterology, The First Hospital of Lanzhou University, …. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Proteomics, Geranyltranstransferase. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary liver cancer is a leading cause of cancer-related death worldwide, and hepatocellular carcinoma (HCC) accounts for most cases. This study aimed to clarify the expression pattern, biological role, therapeutic relevance, and phosphoproteomic impact of farnesyl diphosphate synthase (FDPS) in HCC. FDPS expression was assessed in public datasets and clinical specimens using quantitative real-time polymerase chain reaction and immunohistochemistry. Its function was investigated through small interfering RNA-mediated silencing, lentiviral overexpression, pamidronate treatment, in vitro proliferation, migration, invasion, and apoptosis assays, xenograft models, phosphoproteomic profiling, and Western blot validation. FDPS was upregulated in HCC tissues and was potentially associated with poorer survival. FDPS silencing reduced HCC cell proliferation, migration, invasion, and tumorigenicity and increased apoptosis, whereas FDPS overexpression produced opposite effects. Pamidronate, a selective FDPS inhibitor, suppressed malignant phenotypes in vitro and inhibited tumor growth in vivo. Phosphoproteomic analysis revealed extensive phosphorylation changes after FDPS depletion, with enrichment in pathways related to GTPase and protein kinase C activation, glucose metabolism, cytoskeletal remodeling, immune regulation, cell cycle control, Golgi function, and ErbB and phospholipase D signaling. FDPS knockdown was further associated with decreased B-cell lymphoma 2 expression, reduced phosphorylation of Caspase-9 at Ser196, increased cleaved Caspase-3, and reduced phosphorylation of mechanistic target of rapamycin at Ser2448. Collectively, these findings suggest that FDPS contributes to HCC progression and may serve as a candidate biomarker and therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsProteomicsGeranyltranstransferasePhosphoproteinsHumansAnimalsCell ProliferationApoptosisDisease ProgressionCell Line, TumorMiceCell MovementGene Expression Regulation, NeoplasticPamidronateMice, NudePhosphorylationMale

Substanzen

GeranyltranstransferasePhosphoproteinsPamidronate

Autor:innen und Institutionen

  • The First School of Clinical Medicine, Lanzhou University, Lanzhou, China; Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China; Gansu Province Clinical Research Center for Digestive…
  • School of Public Health, Lanzhou University, Lanzhou, China.
  • Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China; Gansu Province Clinical Research Center for Digestive Diseases, The First Hospital of Lanzhou University, Lanzhou, China.

Zitieren

APA

Yue, H., Wu, G., Jiang, N., Li, R., Zheng, Y., Wang, Y., Hu, Z., & Zhou, Y. (2026). FDPS links tumor progression, phosphoproteomic reprogramming, and therapeutic vulnerability in hepatocellular carcinoma. Biomolecules and Biomedicine. https://doi.org/10.17305/bb.2026.13996

Vancouver

Yue H, Wu G, Jiang N, Li R, Zheng Y, Wang Y, et al. FDPS links tumor progression, phosphoproteomic reprogramming, and therapeutic vulnerability in hepatocellular carcinoma. Biomolecules and Biomedicine. 2026. doi:10.17305/bb.2026.13996

BibTeX
@article{Yue2026,
  author = {Yue, Hanxun and Wu, Guozhi and Jiang, Na and Li, Renpeng and Zheng, Ya and Wang, Yuping and Hu, Zenan and Zhou, Yongning},
  title = {FDPS links tumor progression, phosphoproteomic reprogramming, and therapeutic vulnerability in hepatocellular carcinoma},
  journal = {Biomolecules and Biomedicine},
  year = {2026},
  doi = {10.17305/bb.2026.13996}
}
Kostenlos starten →